S. Yousuf Zafar

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly, Jaffer A. Ajani, Thomas Zander et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text

The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience

S. Yousuf Zafar, Jeffrey Peppercorn, Deborah Schrag et al. · The Oncologist · 2013 · 1.1K citations · Full text

Financial Toxicity of Cancer Care: It’s Time to Intervene

S. Yousuf Zafar · JNCI Journal of the National Cancer Institute · 2015 · 525 citations · Full text

Extreme Financial Distress, Cancer Management, Financial Protection +16

Financial toxicity, Part I: a new name for a growing problem.

S. Yousuf Zafar, Amy P. Abernethy · PubMed · 2013 · 499 citations

Population Health Sciences, Financial Risk, Financial Practice +24

Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness

Jean S. Kutner, Patrick J. Blatchford, Donald H. Taylor et al. · JAMA Internal Medicine · 2015 · 479 citations · Full text